Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections
Clinical trial NCT03176459 · COMPLETED
Trial details
- NCT number
- NCT03176459
- Sponsor
- Pacira Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-11-20
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.